Got everything. Here's your full exam-ready crash course - everything from both PDFs, organized for fast MCQ recall:
🏥 PEDIATRIC JAUNDICE IN OLDER CHILDREN - EXAM CRASH COURSE
📌 PART 1: TABLE 362-2 PDF
🔴 JAUNDICE IN OLDER CHILDREN - OVERVIEW
- Jaundice = total bilirubin >1 mg/dL
- Much less common in older children vs neonates
- Two types:
| Type | Key Conditions |
|---|
| Unconjugated | Hemolytic anemia, Gilbert syndrome, Crigler-Najjar |
| Conjugated | Viral hepatitis, metabolic disease, biliary disorders, autoimmune |
🟡 UNCONJUGATED HYPERBILIRUBINEMIA
Gilbert Syndrome
- Rare autosomal recessive
- Defect in UDPGT (UDP glucuronosyl transferase)
- Mild unconjugated bili (usually ≤5 mg/dL); otherwise healthy
- Triggered by: infection, fasting, vigorous exercise
Crigler-Najjar Syndrome
- Type 1: Complete absence of UDPGT - severe, life-threatening
- Type 2: Limited activity of UDPGT - less severe
- Phenobarbital can induce the enzyme in Type 2 (not Type 1!)
💡 MCQ trick: Phenobarbital works in Crigler-Najjar Type 2 only
🟠 VIRAL HEPATITIS
Key Distinguishing Features (HIGH-YIELD!)
| Feature | HAV | HBV | HCV | HDV | HEV |
|---|
| Incubation | 15-19 days (shortest!) | 3 months (avg) | - | - | - |
| Route | Fecal-oral | Blood/body fluids | Blood | Blood | Fecal-oral |
| Acute only | ✅ | - | - | - | ✅ |
| Chronic | ❌ | ✅ | ✅ | ✅ | ❌ |
| Fulminant | - | ✅ | - | ✅ | ✅ |
| Perinatal | - | ✅ (up to 90%) | ✅ | ✅ | - |
HAV Key Points
- RNA virus, Picornavirus family
- Most common cause of viral hepatitis
- Asymptomatic in <5 yr old, symptomatic in older
- Communicable: 2 weeks BEFORE to 7 days AFTER jaundice
- Duration: 7-14 days
- Dx: Anti-HAV (detectable when symptoms appear; positive for 4-6 months)
- Vaccine: at 12 months, booster at least 6 months after
- Complications: Acute liver failure, prolonged cholestatic syndrome
HBV Key Points
- dsDNA virus, Hepadnaviridae family; 8 genotypes (A-H); B & C prevalent in Asia
- Perinatal transmission: up to 90% if mother is HBeAg-positive and untreated
- Does NOT spread by breastfeeding, kissing, hugging, or sharing utensils
- Pathogenesis: immune-mediated (predominant in HBV)
- Chronic treatment: only in immune-active form (elevated ALT/AST + progressive fibrosis)
Lab findings in Viral Hepatitis
- ALT/AST elevated - does NOT correlate with severity
- Rapidly falling ALT + rising PT = POOR outcome!
- Conjugated bilirubin normalizes first (before ALT/AST)
- ALP, 5-nucleotidase, GGT, urobilinogen elevated during acute phase
🔵 AUTOIMMUNE HEPATITIS (AIH)
Type 1 vs Type 2 - Classic MCQ!
| Feature | Type 1 | Type 2 |
|---|
| Autoantibodies | ANA, anti-SMA (anti-smooth muscle), anti-actin | Anti-LKM1 (liver-kidney microsome), anti-LC1 |
| Age | Any age | Predominantly childhood |
| Gender | Female ~75% | Female ~95% |
| Treatment failure | Infrequent | Frequent |
| Need for long-term maint. | Variable | ~100% |
| Relapse after withdrawal | Variable | Common |
Diagnosis Criteria
- Positive: Female + elevated transaminases (NOT ALP) + elevated γ-globulin + autoantibodies
- Negative: no viral markers, no drug/blood exposure, negligible alcohol
Labs
- Aminotransferase: 100-300 IU/L (up to 1,000 IU/L in symptomatic)
- Bilirubin: 2-10 mg/dL
- IgG >16 g/L (hypergammaglobulinemia)
- Associated HLA: DR3, DR4, DR7
Treatment
- Prednisone 1-2 mg/kg/day, then taper to 0.1-0.3 mg/kg/day
- Poor responders add: Azathioprine or 6-mercaptopurine
- Goal: ALT <2x upper limit of normal
-
75% remission on initial therapy; 50% relapse after withdrawal
- Progression to cirrhosis → liver transplant
🟢 DRUG-INDUCED LIVER INJURY (DILI) - Table 363-1
Drug Patterns (HIGH-YIELD TABLE!)
| Pattern | Drug |
|---|
| Centrilobular necrosis | Acetaminophen, Halothane |
| Microvesicular steatosis | Valproic acid |
| Acute hepatitis | Isoniazid |
| General hypersensitivity | Sulfonamides, Phenytoin |
| Fibrosis | Methotrexate |
| Cholestasis | Chlorpromazine, Erythromycin, Estrogens |
| Sinusoidal obstruction (veno-occlusive) | Irradiation + Busulfan, Cyclophosphamide |
| Portal/hepatic vein thrombosis | Estrogens, Androgens |
| Biliary sludge | Ceftriaxone |
| Hepatic adenoma / HCC | Oral contraceptives, Anabolic steroids |
CYP450 Inducers (memorize!)
Ethanol, Phenobarbital, Phenytoin, Carbamazepine, Rifampicin, INH, Omeprazole
DILI Patterns
- Hepatitic: fatigue, anorexia, vomiting; isolated aminotransferase elevation
- Cholestatic: jaundice, pruritus; elevated ALP & GGT; mild aminotransferases
- Mixed: both
- Drug hypersensitivity: fever, rash, eosinophilia, lymphadenopathy, multi-organ
Treatment
- Acetaminophen → N-acetylcysteine (within 16 hr!)
- Valproic acid → IV L-carnitine
🟣 WILSON'S DISEASE
- Autosomal recessive copper storage disease
- Defect in ATP7B gene → defective ceruloplasmin incorporation → copper accumulates
- Hepatolenticular degeneration
- Hepatic involvement precedes neurologic manifestation by up to 10 yr
- Acute liver failure: 3x more common in girls
- Manifests as early as 2-3 yr (complete gene absence)
Think Wilson's when:
Unexplained liver disease + neurologic symptoms + acute hemolysis + psychiatric changes + Fanconi syndrome + bone/muscle disease
Treatment
- Dietary copper restriction <1 mg/day (avoid liver, shellfish, nuts, chocolate)
- D-Penicillamine (chelation)
- Trientine (alternative chelation)
- Zinc 25 mg 3x/day in children >5 yr (adjuvant/maintenance/primary)
- Liver transplant: 85-90% survival, curative
🟤 CHOLEDOCHAL CYST
- Congenital dilation of biliary tree
- 75% cases manifest during childhood
- Classic triad in older children: Abdominal pain + Jaundice + Mass
- Infants: cholestatic jaundice (dark urine, acholic stool)
- Acute cholangitis: fever + RUQ pain + jaundice + leukocytosis
- Dx: Ultrasonography or MRCP
- Treatment: Primary excision + Roux-en-Y choledochojejunostomy
⚪ LIVER ABSCESS
- Usually seen <6 yr old
- 70% solitary; 75% in right lobe
- Most common organism: S. aureus, Streptococcus spp., E. coli, Klebsiella, Salmonella
- In endemic areas: Entamoeba histolytica (amoebic abscess)
- 50% are polymicrobial; cryptogenic = often monomicrobial
- Imaging: Elevated hemidiaphragm on CXR; Ultrasound/CT preferred
- Treatment:
- Broad-spectrum antibiotics IV 2-3 weeks, then oral to complete 4-6 weeks
- Amoebic: Metronidazole + Paromomycin
- Multiple/large abscess: CT-guided aspiration or surgical drainage
🔴 ACUTE ACALCULOUS CHOLECYSTITIS
- Uncommon in children; no gallstones
- Most common cause: Infection (Streptococci groups A & B, gram-negative - Salmonella, Leptospira; Parasites - Ascaris, Giardia)
- Dx: US - enlarged, thick-walled gallbladder without calculi; daily US recommended (can become gangrenous)
- Treatment: Antibiotics + Cholecystectomy
📌 PART 2: TYPES OF STONES / CHOLELITHIASIS PDF
💛 CHOLELITHIASIS (Gallstones)
- Rare in healthy children; common with predisposing factors
- 70% pigment stones (most common in children!)
- 15-20% cholesterol stones
- <15% mixed
Pathophysiology
- Cholesterol stones: gallbladder stasis + excess cholesterol → supersaturation → crystallization
- Co-factors: mucin, calcium, apolipoprotein, lecithin
- Biliary pseudolithiasis: Calcium-Ceftriaxone salt precipitates
- Prolonged high-dose Ceftriaxone (>40% treated ≥10 days)
- Presents with jaundice, abdominal pain
- Spontaneously resolves within several months
Clinical Presentation
- >50% have symptoms
- 18% present with complications (pancreatitis, choledocholithiasis, acute cholecystitis)
- Key feature: recurrent colicky pain in RUQ
- Older child: intolerance for fatty foods
Diagnosis
- Ultrasonography = method of choice
- Plain x-ray: only radiopaque (calcified) stones visible; radiolucent = not seen
- Hepatobiliary scintigraphy (HIDA scan): adjunct; shows cholecystitis
Treatment
- Symptomatic: Laparoscopic cholecystectomy
- Operative cholangiography: at surgery to detect unsuspected CBD stones
- ERCP with extraction: older children and adolescents
- Asymptomatic: May resolve spontaneously; advise parents
🔴 QUICK COMPARISON TABLE (HIGH-YIELD!)
| Cholelithiasis | Cholecystitis | Choledocholithiasis | Cholangitis |
|---|
| Meaning | Stones in GB | Inflammation GB/cystic duct | Stones in CBD | Inflammation of bile ducts |
| Symptoms | RUQ pain (biliary colic), N/V | RUQ pain, N/V, Fever | RUQ pain, Jaundice | RUQ pain, Jaundice, Fever |
| Diagnosis | RUQ US | RUQ US + HIDA | RUQ US + ERCP/MRCP | RUQ US + ERCP/MRCP |
| Treatment | Elective cholecystectomy | Antibiotics + cholecystectomy | ERCP | Antibiotics + ERCP + cholecystectomy |
🟠 ACUTE PANCREATITIS
Etiology (Children)
- Most common pancreatic disorder in children
- Top causes:
- Blunt abdominal injuries (most common cause)
- Hemolytic uremic syndrome (HUS)
- Inflammatory bowel disease
- Biliary stones / microlithiasis
- Drug toxicity: valproic acid, L-asparaginase, 6-mercaptopurine, azathioprine
Pathophysiology
- Ductal disruption → premature activation of trypsinogen → trypsin → activates proenzymes → autodigestion
Severity Classification (HIGH-YIELD!)
| Mild | Moderately Severe | Severe |
|---|
| Organ failure | None | Transient (<48h) | Persists >48h |
| Necrosis | None | Sterile necrosis possible | Hemorrhagic mass |
| Signs | Abdominal pain, vomiting | - | Cullen sign (periumbilical blue) + Grey Turner sign (flank blue) |
| Prognosis | Excellent; resolves in 1st week | - | 20% mortality |
💡 Cullen sign = periumbilical bluish discoloration; Grey Turner = flanks - both = Severe pancreatitis
Diagnosis: Lipase vs Amylase
| Lipase (preferred!) | Amylase |
|---|
| Why | More specific for pancreatitis | Elevated in non-pancreatic diseases too |
| Rises | 4-8 hr, peaks 24-48 hr | Up to 4 days |
| Stays elevated | 8-14 days longer | - |
| Normal at start | No | 10-15% initially normal |
Other labs: hemoconcentration, leukocytosis, hyperglycemia, glucosuria, hypocalcemia, elevated GGT, hyperbilirubinemia
- CT scan for severe: pancreatic enlargement, hypoechoic edematous pancreas, fluid collections, abscess
- MRCP/ERCP: recurrent or non-resolving pancreatitis
Treatment
| Mild | Severe |
|---|
| Analgesia | Antibiotics |
| Fluid/electrolyte balance | Gastric acid suppression |
| NPO if vomiting; refeed with resolution of vomiting | Enteral feeding within 2-3 days |
| Endoscopic/surgical therapy for complications |
- Prognosis: Uncomplicated → recovery in 4-5 days
🔵 PORTAL HYPERTENSION
- Portal pressure >10-12 mm Hg (normal: 7 mm Hg)
Causes by Location
| Prehepatic (extrahepatic) | Intrahepatic | Posthepatic |
|---|
| Portal vein thrombosis (most common in children) | Cirrhosis (predominant) | Budd-Chiari syndrome |
| Omphalitis | Congenital hepatic fibrosis | Veno-occlusive disease |
| AV fistula | Schistosomiasis | IVC occlusion |
| Portal vein anomalies | Malignant infiltration | Right heart dysfunction |
💡 Suspect portal vein obstruction in a child <6 yr with isolated splenomegaly who had a complicated neonatal course
Clinical Manifestations
- Most common: Esophageal variceal bleed (hematemesis/melena)
- Hard to control if secondary to cirrhosis
- 2nd most common: Splenomegaly (with/without hypersplenism)
- Ascites (more common in intrahepatic disease)
- Growth retardation (cirrhosis > extrahepatic)
- Hepatopulmonary syndrome: ≥10% of patients; arterial oxygenation defect from intrapulmonary microvascular dilation
Diagnosis
- Doppler US: reversal of portal flow (hepatofugal flow) = variceal bleeding
- Endoscopy: most reliable for detecting esophageal varices + source of GI bleed
- Best noninvasive predictors: Platelet count + spleen length + serum albumin
- Contrast echocardiography: for hepatopulmonary syndrome - delayed appearance of microbubbles in left heart
Treatment - Acute Variceal Bleed
- Fluid resuscitation → RBC transfusion
- IV H2 blocker or PPI
- Vitamin K + platelets/FFP (if coagulopathy)
- Vasopressin → increases splanchnic vascular tone → decreases portal blood flow
- Octreotide → decreases splanchnic blood flow
- Endoscopic: rubber band ligation (more effective) or sclerotherapy
- Sengstaken-Blakemore tube: if persistently bleeding
Surgical Options
- TIPS (transjugular intrahepatic portosystemic shunt): risk for hepatic encephalopathy
- Distal splenorenal shunt: for esophageal variceal bleed; best with well-preserved liver
- Rex shunt: for portal vein thrombosis; restores physiologic flow; improves growth and cognition
- Liver transplant: for intrahepatic disease / cirrhosis / hepatopulmonary syndrome
- β-blockers (non-selective): long-term; reduce heart rate by ≥25%
Prognosis
- Intrahepatic: poor prognosis
- Portal vein obstruction: >50% experience bleeding during adolescence; can develop portal biliopathy (bile duct compression from collaterals)
🟣 FULMINANT HEPATIC FAILURE (Acute Liver Failure)
Definition (Pediatric ALF)
- Acute liver injury <8 weeks duration
- No chronic liver disease
- Coagulopathy:
- PT >15 sec or INR >1.5 not corrected by Vit K + encephalopathy, OR
- PT >20 sec or INR >2 (regardless of encephalopathy)
Causes
- Viral: HAV, HBV, HCV, HEV + EBV, HSV, CMV, Adenovirus
- Drugs: Acetaminophen = most common
- Autoimmune hepatitis
- Metabolic: Wilson disease, Galactosemia, Hereditary tyrosinemia
- Vascular/ischemic
Warning Signs
- Rapid decrease in liver size without clinical improvement = OMINOUS sign
- Progressive jaundice, fetor hepaticus, fever, ascites, diathesis
Multi-Organ Involvement (Memorize!)
- Brain: hepatic encephalopathy, cerebral edema, intracranial hypertension, seizures
- Kidney: hepatorenal syndrome
- Lungs: ARDS, hepatopulmonary syndrome
- Heart: high output state
- Bone marrow: anemia, thrombocytopenia
- Liver: hypoglycemia, hyperammonemia, coagulopathy, lactic acidosis
Labs
- Bilirubin + aminotransferases: markedly elevated
- Aminotransferase decreases as patient deteriorates (bad sign!)
- PT/INR prolonged (often don't normalize)
- Hypoglycemia, hypokalemia, hyponatremia, metabolic acidosis
Treatment - Specific Antidotes (HIGH-YIELD!)
| Cause | Treatment |
|---|
| Acetaminophen | N-acetylcysteine |
| Herpes simplex | Acyclovir |
| Amanita mushrooms | Penicillin |
| HBV | Entecavir or Lamivudine |
| Autoimmune hepatitis | Prednisone |
| Others (valproic acid) | IV L-carnitine |
- Liver transplant: hepatic encephalopathy stages III-IV
Prognosis
- 90% survival: Acetaminophen OD + Fulminant Hepatitis A
- 40% survival: Idiopathic + acute-onset Wilson disease
- Extremely poor: stage IV coma
- Associated with mortality: Age <1 yr, Stage 4 encephalopathy, INR >4
🟡 ASCITES
- Hallmark: abdominal distention
- Signs: bulging flanks, shifting dullness, fluid wave, puddle sign
- Moderate: early satiety, dyspnea
- Tense: umbilical herniation
SERUM-ASCITES ALBUMIN GRADIENT (SAAG)
| SAAG | Cause |
|---|
| >1.1 g/dL (high gradient) | Portal hypertension |
| <1.1 g/dL (low gradient) | Non-portal hypertensive (infection, malignancy) |
Treatment
- Sodium restriction + Spironolactone + Furosemide
- Albumin infusion
- Large volume paracentesis or TIPS
- Risk: Spontaneous bacterial peritonitis (SBP)
🔴 PERITONITIS
Primary (Spontaneous Bacterial) Peritonitis
- No intraabdominal source
- Most common in: Cirrhosis and Nephrotic syndrome
- Pathogen: Pneumococci most common; also Gr A strep, E. coli, Klebsiella
- Paracentesis: WBC ≥250 cells/mm³ with >50% PMN
- Treatment: Cefotaxime (broad spectrum initially); vancomycin for resistant pneumococci; 10-14 days
- Monomicrobial
Secondary Peritonitis
- Has an intraabdominal source
- Most common: Perforated appendix
- In neonates: Necrotizing enterocolitis
- Paracentesis: WBC ≥250 + elevated protein (>1 g/dL) + low glucose (<50 mg/dL)
- X-ray: Free air in peritoneal cavity
- Treatment: Polymicrobial coverage
- Lower GIT perforation: Ampicillin + Gentamicin + Clindamycin/Metronidazole
- PD catheter-related: Intraperitoneal Cefepime or Cefazolin + Ceftazidime
- Surgery once stabilized
⚡ RAPID MCQ FIRE - KEY NUMBERS
| Fact | Number |
|---|
| Jaundice = bilirubin | >1 mg/dL |
| HAV incubation (shortest!) | 15-19 days |
| HBV incubation | ~3 months |
| Perinatal HBV transmission (untreated HBeAg+) | up to 90% |
| Portal HTN pressure | >10-12 mm Hg (normal 7) |
| Severe pancreatitis mortality | 20% |
| Lipase peak | 24-48 hr, stays up 8-14 days |
| ALF duration | <8 weeks |
| ALF INR (with encephalopathy) | >1.5 |
| ALF INR (without encephalopathy) | >2 |
| SAAG for portal HTN | >1.1 g/dL |
| SBP paracentesis WBC | ≥250 cells/mm³, >50% PMN |
| AIH remission rate | >75% |
| AIH relapse rate | 50% |
| Wilson's liver transplant survival | 85-90% |
| ALF survival in acetaminophen/HAV | 90% |
| Choledochal cyst: cases in childhood | 75% |
| Liver abscess: right lobe | 75%, solitary 70% |
| Pigment stones in children | 70% |
| Cholelithiasis with symptoms | >50% |
| Cholelithiasis with complications | 18% |
| HAV communicability before jaundice | 2 weeks |
| β-blocker: heart rate reduction goal | ≥25% |
🔑 TOP MCQ TRIGGERS - WHAT DIAGNOSES WHAT?
| Scenario | Answer |
|---|
| Child <5, fasting, stress → jaundice | Gilbert syndrome |
| Phenobarbital treats hyperbilirubinemia | Crigler-Najjar Type 2 |
| Fecal-oral hepatitis, shortest incubation | HAV |
| dsDNA virus, immune-mediated hepatitis | HBV |
| Fatty change in hepatitis | HCV |
| Female, anti-LKM1, severe, childhood | AIH Type 2 |
| Female, ANA + anti-SMA | AIH Type 1 |
| ATP7B mutation, copper, Kayser-Fleischer | Wilson disease |
| D-Penicillamine, Zinc treatment | Wilson disease |
| Periumbilical + flank bruising in pancreatitis | Cullen + Grey Turner = Severe |
| Best test for pancreatitis | Lipase |
| Gallstone imaging of choice | Ultrasonography |
| Ceftriaxone → biliary sludge | Biliary pseudolithiasis |
| N-acetylcysteine antidote | Acetaminophen toxicity |
| IV L-carnitine antidote | Valproic acid toxicity |
| Hepatofugal flow on Doppler | Portal HTN + variceal bleeding |
| Child <6, isolated splenomegaly, neonatal hx | Portal vein obstruction |
| Best noninvasive predictors portal HTN | Platelet count + spleen length + albumin |
| Rex shunt used for | Portal vein thrombosis |
| SAAG >1.1 | Portal hypertension |
| Ascites + no intraabdominal source | Primary/SBP |
| SBP most common organism | Pneumococcus |
| SBP antibiotic | Cefotaxime |
| Perforated appendix peritonitis | Secondary peritonitis |
| Classic triad older child biliary | Pain + Jaundice + Mass = Choledochal cyst |
| Acalculous cholecystitis organism | Streptococcus (Grp A & B) |
| Liver abscess: most common lobe | Right lobe (75%) |
Good luck on your exam! You've got this. 💪